Oxford Technology Management
VC Fund
Oxford, United Kingdom
Oxford Technology Management is a VC fund in Oxford focused on Biotechnology and Health Care. Oxford Technology Management was founded by Lucius Cary, and since 1983 has specialised in making and managing investments in start-up and early stage technology-based businesses with high growth prospects.The OTM team are all scientists or engineers by background, and understanding the technology is the starting point for any investment thatthey may make.The Investment policy of Oxford Technology Management is to construct a portfolio of investments with the following characteristics:unlisted, UK based, technology businesses investments typically in the range of £100,000 - £2,000,000, although it can then invest similar amounts in subsequent rounds in most cases located within easy reach of Oxford to allow a more 'hands on' management strategy It is expected that approximately half of the funds will be invested in early stage companies (those which have achieved some initial sales) and the balance in start-up companies which are at an earlier stage.
- Total investments:
- 110
- Last investment:
- Lead investor:
- 7%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Oxford Technology Management invests in
Stages Oxford Technology Management invests in
Countries Oxford Technology Management invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
1 more contact available
Round size
- Seed
- $33k–$2.2M
- Series A
- $786k–$7.9M
Investment Focus
Industry
- Biotechnology 26 (24%)
- Health Care 20 (18%)
- Software 16 (15%)
- Manufacturing 15 (14%)
- Medical 12 (11%)
Stage
- Seed 44 (40%)
- Funding Round 31 (28%)
- Series A 7 (6%)
- Series B 4 (4%)
- Pre-Seed 2 (2%)
Country
- United Kingdom 75 (68%)
- United States 3 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Andrea Mica
Director
|
Director | Total investments: 0 | Find email | |
David Livesley
Non-Executive Chairman
|
Non-Executive Chairman | Total investments: 0 | Find email | |
Lucius Cary
Founder and Managing Director
|
Founder and Managing Director | Total investments: 2 | Find email | |
Michael Penington
Partner
|
Partner | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
OrganOx
|
OrganOx Limited was founded in 2008 to exploit normothermic preservation technology invented by Prof Peter Friend and colleagues and further developed by Prof Constantin Coussios at the University of Oxford. | $160M / Venture - Series Unknown / Feb 24, 2025 | |
Metacarpal
|
Metacarpal broke the mould by creating the first bionic yet fully mechanical hand prosthesis. Capable of switching grips yet offering responsive and precise control already familiar to the user, they aim to also supply prosthetics to those most in need in the developing world. | $1.1M / Seed / Aug 27, 2024 | |
CryoLogyx
|
CryoLogyx is an early-stage biotechnology business that develops frozen, ready-to-use cells for drug discovery. Their exclusive technology is transforming cell freezing, storage, and transportation. Innovation ensures the delivery of viable cells and cell therapies in the appropriate format, ready to use whenever our customers require them. | $636.3K / Seed / Mar 18, 2024 | |
MitoRx Therapeutics
|
MitoRx Therapeutics is a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction. | $5M / Seed / Dec 13, 2023 | |
digiLab Solutions Limited
|
digiLab is an AI company building uncertainty-aware, explainable software for critical industries like fusion energy, defence, sustainability, and advanced infrastructure. Its flagship platform, The Uncertainty Engine, helps organisations explore, reason, and decide with AI they can trust. Combining frontier science with pragmatic delivery, digiLabsupports customers across government and industry, and leads cutting-edge challenge projects through its applied research unit, theLab. | $1.1M / Seed / Jan 31, 2023 | |
OxCan
|
OxCan is a startup that uses machine learning and liquid biopsy for early lung cancer detection. | $3.6M / Seed / Jan 10, 2023 | |
|
MitoRx Therapeutics
|
MitoRx Therapeutics is a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction. | Seed / Apr 25, 2022 | |
|
digiLab Solutions Limited
|
digiLab is an AI company building uncertainty-aware, explainable software for critical industries like fusion energy, defence, sustainability, and advanced infrastructure. Its flagship platform, The Uncertainty Engine, helps organisations explore, reason, and decide with AI they can trust. Combining frontier science with pragmatic delivery, digiLabsupports customers across government and industry, and leads cutting-edge challenge projects through its applied research unit, theLab. | $202K / Pre-Seed / Jan 31, 2022 | |
|
OxCan
|
OxCan is a startup that uses machine learning and liquid biopsy for early lung cancer detection. | $1.8M / Seed / Sep 06, 2021 | |
Mach42
|
Machine Discovery is a University of Oxford spin-out commercializing new machine learning technology. We leverage proprietary neural network technology to accelerate expensive calculations — and we do it with minimal data and 99.9% fidelity. | $2.1M / Seed / May 05, 2021 | |
| See all 110 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Oxford Technology Management invest in?
Oxford Technology Management invests primarily in Biotechnology, Health Care and Software startups, most often at Seed and Funding Round stage. Most of the 110 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Oxford Technology Management's check size?
Oxford Technology Management typically joins rounds of $33k–$2.2M at Seed and $786k–$7.9M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Oxford Technology Management participates in.
How do I contact Oxford Technology Management?
Public channels for Oxford Technology Management include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Oxford Technology Management?
The team at Oxford Technology Management includes Andrea Mica (Director), David Livesley (Non-Executive Chairman) and Lucius Cary (Founder and Managing Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
